Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Amino-Terminal Brain Natriuretic Peptide and C-Reactive Protein Serum Levels for Predicting Recurrence of Atrial Fibrillation and/or Atrial Flutter After Radiofrequency Catheter Ablation

NCT00315068 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT00315068
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00315068 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Amino-Terminal Brain Natriuretic Peptide and C-Reactive Protein Serum Levels for Predicting Recurrence of Atrial Fibrillation and/or Atrial Flutter After Radiofrequency Catheter Ablation
Lead sponsor
University Hospital, Geneva
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2004
Completion date
August 31, 2007
Enrollment
180
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation